Intensified treatment with high dose Rifampicin and Levofloxacin compared to standard treatment for adult patients with Tuberculous Meningitis (TBM-IT): protocol for a randomized controlled trial
2011

High Dose Rifampicin and Levofloxacin for Tuberculous Meningitis Treatment

Sample size: 750 publication Evidence: high

Author Information

Author(s): Heemskerk Dorothee, Day Jeremy, Chau Tran Thi Hong, Dung Nguyen Huy, Yen Nguyen Thi Bich, Bang Nguyen Duc, Merson Laura, Olliaro Piero, Pouplin Thomas, Caws Maxine, Wolbers Marcel, Farrar Jeremy

Primary Institution: Hospital for Tropical Diseases, Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme

Hypothesis

Current antimycobacterial regimes are not potent enough to treat TBM effectively, as most of the antimycobacterial drugs have very low cerebrospinal fluid penetration.

Conclusion

The study aims to improve treatment outcomes for tuberculous meningitis by using higher doses of rifampicin and adding levofloxacin.

Supporting Evidence

  • Mortality for untreated tuberculous meningitis is 100%.
  • Approximately 25% of HIV-negative and 67% of HIV-positive patients die from tuberculous meningitis.
  • Current treatment regimens have poor penetration into the central nervous system.

Takeaway

This study is testing if giving more medicine can help people with a serious brain infection called tuberculous meningitis get better.

Methodology

A randomized, double blind, placebo-controlled trial comparing standard treatment with intensified treatment using high-dose rifampicin and levofloxacin.

Potential Biases

Potential biases in patient selection and treatment adherence may affect the results.

Limitations

The study may not account for all variables affecting treatment outcomes, and results may not be generalizable to all populations.

Participant Demographics

The study will include 750 patients, with a minimum of 350 HIV-positive patients.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1745-6215-12-25

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication